Geron shares pop in pre-market trade on optimistic clinical trial results for its drug therapy imetelstat

04:01 EDT 18 Jun 2018 | Proactive Investors

Its drug therapy imetelstat is used to treat lower-risk myelodysplastic syndrome, a type of blood cancer

More From BioPortfolio on "Geron shares pop in pre-market trade on optimistic clinical trial results for its drug therapy imetelstat"